Dalian Corvivo Medical Technology Co., Ltd. was established on June 13, 2016, with a registered capital of 20 million yuan. Located in the Dalian Science and Technology Innovation Center of Gaoxin Park. The company is committed to the research and development of high-end medical equipment and equipment such as implants and interventions in cardiovascular and critical medicine-related fields. It is a specialized enterprise integrating R&D, manufacturing, sales and service, and its products are positioned in the global market.

The company's R&D team consists of world-class clinical experts and experienced medical device product development experts, engineering and medical device quality system engineers. The R&D team has high professional theoretical knowledge and rich R&D practice in the research and development of high-end medical devices. Experience has provided a strong talent guarantee for project research and development. The company consists of 5 departments including R&D department, quality control department, production department, sales department and production department. There are 15 people in total, 3 doctors or above, 4 masters and 6 undergraduates.

The company has more than 1200 sets of bases to meet the requirements of medical device development, including 800-level clean rooms and supporting facilities in compliance with GMP requirements, and more than 400 flats in modern office space, which can meet the research and development and production of high-end medical devices of Class II and Class III. Claim.

The company is honored:

(1) Obtained the eighth batch of Haichuang project support in Dalian in 2017;

(2) Supported by Dalian's 2018 key science and technology plan project;

(3) Awarded the Outstanding Enterprise Award in the Biomedical Industry of the 7th China Innovation and Entrepreneurship Competition in 2018.